Global Opioids Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period.
The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Opioids Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Opioids Drug market.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
Key Features:
The report on Opioids Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Opioids Drug market. It may include historical data, market segmentation by Type (e.g., Oxycodone, Hydromorphone), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Opioids Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Opioids Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Opioids Drug industry. This include advancements in Opioids Drug technology, Opioids Drug new entrants, Opioids Drug new investment, and other innovations that are shaping the future of Opioids Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Opioids Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Opioids Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Opioids Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Opioids Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Opioids Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Opioids Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Opioids Drug market.
Market Segmentation:
Opioids Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Opioids Drug market?
What factors are driving Opioids Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioids Drug market opportunities vary by end market size?
How does Opioids Drug break out type, application?
According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period.
The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Opioids Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Opioids Drug market.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
Key Features:
The report on Opioids Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Opioids Drug market. It may include historical data, market segmentation by Type (e.g., Oxycodone, Hydromorphone), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Opioids Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Opioids Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Opioids Drug industry. This include advancements in Opioids Drug technology, Opioids Drug new entrants, Opioids Drug new investment, and other innovations that are shaping the future of Opioids Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Opioids Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Opioids Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Opioids Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Opioids Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Opioids Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Opioids Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Opioids Drug market.
Market Segmentation:
Opioids Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Pain Relief
- Anesthesia
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
What is the 10-year outlook for the global Opioids Drug market?
What factors are driving Opioids Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioids Drug market opportunities vary by end market size?
How does Opioids Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioids Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Opioids Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Opioids Drug by Country/Region, 2019, 2023 & 2030
2.2 Opioids Drug Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.3 Opioids Drug Sales by Type
2.3.1 Global Opioids Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Opioids Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Opioids Drug Sale Price by Type (2019-2024)
2.4 Opioids Drug Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Others
2.5 Opioids Drug Sales by Application
2.5.1 Global Opioids Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Opioids Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Opioids Drug Sale Price by Application (2019-2024)
3 GLOBAL OPIOIDS DRUG BY COMPANY
3.1 Global Opioids Drug Breakdown Data by Company
3.1.1 Global Opioids Drug Annual Sales by Company (2019-2024)
3.1.2 Global Opioids Drug Sales Market Share by Company (2019-2024)
3.2 Global Opioids Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Opioids Drug Revenue by Company (2019-2024)
3.2.2 Global Opioids Drug Revenue Market Share by Company (2019-2024)
3.3 Global Opioids Drug Sale Price by Company
3.4 Key Manufacturers Opioids Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Drug Product Location Distribution
3.4.2 Players Opioids Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOIDS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Opioids Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Opioids Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Opioids Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Opioids Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Opioids Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Opioids Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Opioids Drug Sales Growth
4.4 APAC Opioids Drug Sales Growth
4.5 Europe Opioids Drug Sales Growth
4.6 Middle East & Africa Opioids Drug Sales Growth
5 AMERICAS
5.1 Americas Opioids Drug Sales by Country
5.1.1 Americas Opioids Drug Sales by Country (2019-2024)
5.1.2 Americas Opioids Drug Revenue by Country (2019-2024)
5.2 Americas Opioids Drug Sales by Type
5.3 Americas Opioids Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioids Drug Sales by Region
6.1.1 APAC Opioids Drug Sales by Region (2019-2024)
6.1.2 APAC Opioids Drug Revenue by Region (2019-2024)
6.2 APAC Opioids Drug Sales by Type
6.3 APAC Opioids Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioids Drug by Country
7.1.1 Europe Opioids Drug Sales by Country (2019-2024)
7.1.2 Europe Opioids Drug Revenue by Country (2019-2024)
7.2 Europe Opioids Drug Sales by Type
7.3 Europe Opioids Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioids Drug by Country
8.1.1 Middle East & Africa Opioids Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Opioids Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Opioids Drug Sales by Type
8.3 Middle East & Africa Opioids Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioids Drug
10.3 Manufacturing Process Analysis of Opioids Drug
10.4 Industry Chain Structure of Opioids Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioids Drug Distributors
11.3 Opioids Drug Customer
12 WORLD FORECAST REVIEW FOR OPIOIDS DRUG BY GEOGRAPHIC REGION
12.1 Global Opioids Drug Market Size Forecast by Region
12.1.1 Global Opioids Drug Forecast by Region (2025-2030)
12.1.2 Global Opioids Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioids Drug Forecast by Type
12.7 Global Opioids Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Opioids Drug Product Portfolios and Specifications
13.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Purdue Pharma
13.2.1 Purdue Pharma Company Information
13.2.2 Purdue Pharma Opioids Drug Product Portfolios and Specifications
13.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Purdue Pharma Main Business Overview
13.2.5 Purdue Pharma Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Opioids Drug Product Portfolios and Specifications
13.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Amneal Pharma
13.4.1 Amneal Pharma Company Information
13.4.2 Amneal Pharma Opioids Drug Product Portfolios and Specifications
13.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Amneal Pharma Main Business Overview
13.4.5 Amneal Pharma Latest Developments
13.5 Collegium
13.5.1 Collegium Company Information
13.5.2 Collegium Opioids Drug Product Portfolios and Specifications
13.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Collegium Main Business Overview
13.5.5 Collegium Latest Developments
13.6 J&J
13.6.1 J&J Company Information
13.6.2 J&J Opioids Drug Product Portfolios and Specifications
13.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 J&J Main Business Overview
13.6.5 J&J Latest Developments
13.7 Endo
13.7.1 Endo Company Information
13.7.2 Endo Opioids Drug Product Portfolios and Specifications
13.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Endo Main Business Overview
13.7.5 Endo Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Opioids Drug Product Portfolios and Specifications
13.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 INSYS
13.9.1 INSYS Company Information
13.9.2 INSYS Opioids Drug Product Portfolios and Specifications
13.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 INSYS Main Business Overview
13.9.5 INSYS Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Opioids Drug Product Portfolios and Specifications
13.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
13.11 Hikma
13.11.1 Hikma Company Information
13.11.2 Hikma Opioids Drug Product Portfolios and Specifications
13.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hikma Main Business Overview
13.11.5 Hikma Latest Developments
13.12 Egalet
13.12.1 Egalet Company Information
13.12.2 Egalet Opioids Drug Product Portfolios and Specifications
13.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Egalet Main Business Overview
13.12.5 Egalet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioids Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Opioids Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Opioids Drug by Country/Region, 2019, 2023 & 2030
2.2 Opioids Drug Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.3 Opioids Drug Sales by Type
2.3.1 Global Opioids Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Opioids Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Opioids Drug Sale Price by Type (2019-2024)
2.4 Opioids Drug Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Others
2.5 Opioids Drug Sales by Application
2.5.1 Global Opioids Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Opioids Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Opioids Drug Sale Price by Application (2019-2024)
3 GLOBAL OPIOIDS DRUG BY COMPANY
3.1 Global Opioids Drug Breakdown Data by Company
3.1.1 Global Opioids Drug Annual Sales by Company (2019-2024)
3.1.2 Global Opioids Drug Sales Market Share by Company (2019-2024)
3.2 Global Opioids Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Opioids Drug Revenue by Company (2019-2024)
3.2.2 Global Opioids Drug Revenue Market Share by Company (2019-2024)
3.3 Global Opioids Drug Sale Price by Company
3.4 Key Manufacturers Opioids Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Drug Product Location Distribution
3.4.2 Players Opioids Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOIDS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Opioids Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Opioids Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Opioids Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Opioids Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Opioids Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Opioids Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Opioids Drug Sales Growth
4.4 APAC Opioids Drug Sales Growth
4.5 Europe Opioids Drug Sales Growth
4.6 Middle East & Africa Opioids Drug Sales Growth
5 AMERICAS
5.1 Americas Opioids Drug Sales by Country
5.1.1 Americas Opioids Drug Sales by Country (2019-2024)
5.1.2 Americas Opioids Drug Revenue by Country (2019-2024)
5.2 Americas Opioids Drug Sales by Type
5.3 Americas Opioids Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioids Drug Sales by Region
6.1.1 APAC Opioids Drug Sales by Region (2019-2024)
6.1.2 APAC Opioids Drug Revenue by Region (2019-2024)
6.2 APAC Opioids Drug Sales by Type
6.3 APAC Opioids Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioids Drug by Country
7.1.1 Europe Opioids Drug Sales by Country (2019-2024)
7.1.2 Europe Opioids Drug Revenue by Country (2019-2024)
7.2 Europe Opioids Drug Sales by Type
7.3 Europe Opioids Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioids Drug by Country
8.1.1 Middle East & Africa Opioids Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Opioids Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Opioids Drug Sales by Type
8.3 Middle East & Africa Opioids Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioids Drug
10.3 Manufacturing Process Analysis of Opioids Drug
10.4 Industry Chain Structure of Opioids Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioids Drug Distributors
11.3 Opioids Drug Customer
12 WORLD FORECAST REVIEW FOR OPIOIDS DRUG BY GEOGRAPHIC REGION
12.1 Global Opioids Drug Market Size Forecast by Region
12.1.1 Global Opioids Drug Forecast by Region (2025-2030)
12.1.2 Global Opioids Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioids Drug Forecast by Type
12.7 Global Opioids Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Opioids Drug Product Portfolios and Specifications
13.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Purdue Pharma
13.2.1 Purdue Pharma Company Information
13.2.2 Purdue Pharma Opioids Drug Product Portfolios and Specifications
13.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Purdue Pharma Main Business Overview
13.2.5 Purdue Pharma Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Opioids Drug Product Portfolios and Specifications
13.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Amneal Pharma
13.4.1 Amneal Pharma Company Information
13.4.2 Amneal Pharma Opioids Drug Product Portfolios and Specifications
13.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Amneal Pharma Main Business Overview
13.4.5 Amneal Pharma Latest Developments
13.5 Collegium
13.5.1 Collegium Company Information
13.5.2 Collegium Opioids Drug Product Portfolios and Specifications
13.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Collegium Main Business Overview
13.5.5 Collegium Latest Developments
13.6 J&J
13.6.1 J&J Company Information
13.6.2 J&J Opioids Drug Product Portfolios and Specifications
13.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 J&J Main Business Overview
13.6.5 J&J Latest Developments
13.7 Endo
13.7.1 Endo Company Information
13.7.2 Endo Opioids Drug Product Portfolios and Specifications
13.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Endo Main Business Overview
13.7.5 Endo Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Opioids Drug Product Portfolios and Specifications
13.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 INSYS
13.9.1 INSYS Company Information
13.9.2 INSYS Opioids Drug Product Portfolios and Specifications
13.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 INSYS Main Business Overview
13.9.5 INSYS Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Opioids Drug Product Portfolios and Specifications
13.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
13.11 Hikma
13.11.1 Hikma Company Information
13.11.2 Hikma Opioids Drug Product Portfolios and Specifications
13.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hikma Main Business Overview
13.11.5 Hikma Latest Developments
13.12 Egalet
13.12.1 Egalet Company Information
13.12.2 Egalet Opioids Drug Product Portfolios and Specifications
13.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Egalet Main Business Overview
13.12.5 Egalet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioids Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Opioids Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oxycodone
Table 4. Major Players of Hydromorphone
Table 5. Major Players of Codeine
Table 6. Major Players of Fentanyl
Table 7. Global Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 8. Global Opioids Drug Sales Market Share by Type (2019-2024)
Table 9. Global Opioids Drug Revenue by Type (2019-2024) & ($ million)
Table 10. Global Opioids Drug Revenue Market Share by Type (2019-2024)
Table 11. Global Opioids Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 13. Global Opioids Drug Sales Market Share by Application (2019-2024)
Table 14. Global Opioids Drug Revenue by Application (2019-2024)
Table 15. Global Opioids Drug Revenue Market Share by Application (2019-2024)
Table 16. Global Opioids Drug Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Opioids Drug Sales by Company (2019-2024) & (M Units)
Table 18. Global Opioids Drug Sales Market Share by Company (2019-2024)
Table 19. Global Opioids Drug Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Opioids Drug Revenue Market Share by Company (2019-2024)
Table 21. Global Opioids Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Opioids Drug Producing Area Distribution and Sales Area
Table 23. Players Opioids Drug Products Offered
Table 24. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Opioids Drug Sales by Geographic Region (2019-2024) & (M Units)
Table 28. Global Opioids Drug Sales Market Share Geographic Region (2019-2024)
Table 29. Global Opioids Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Opioids Drug Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Opioids Drug Sales by Country/Region (2019-2024) & (M Units)
Table 32. Global Opioids Drug Sales Market Share by Country/Region (2019-2024)
Table 33. Global Opioids Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Opioids Drug Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Opioids Drug Sales by Country (2019-2024) & (M Units)
Table 36. Americas Opioids Drug Sales Market Share by Country (2019-2024)
Table 37. Americas Opioids Drug Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Opioids Drug Revenue Market Share by Country (2019-2024)
Table 39. Americas Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 40. Americas Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 41. APAC Opioids Drug Sales by Region (2019-2024) & (M Units)
Table 42. APAC Opioids Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Opioids Drug Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Opioids Drug Revenue Market Share by Region (2019-2024)
Table 45. APAC Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 46. APAC Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 47. Europe Opioids Drug Sales by Country (2019-2024) & (M Units)
Table 48. Europe Opioids Drug Sales Market Share by Country (2019-2024)
Table 49. Europe Opioids Drug Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Opioids Drug Revenue Market Share by Country (2019-2024)
Table 51. Europe Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 52. Europe Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 53. Middle East & Africa Opioids Drug Sales by Country (2019-2024) & (M Units)
Table 54. Middle East & Africa Opioids Drug Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Opioids Drug Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Opioids Drug Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 58. Middle East & Africa Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 59. Key Market Drivers & Growth Opportunities of Opioids Drug
Table 60. Key Market Challenges & Risks of Opioids Drug
Table 61. Key Industry Trends of Opioids Drug
Table 62. Opioids Drug Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Opioids Drug Distributors List
Table 65. Opioids Drug Customer List
Table 66. Global Opioids Drug Sales Forecast by Region (2025-2030) & (M Units)
Table 67. Global Opioids Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Opioids Drug Sales Forecast by Country (2025-2030) & (M Units)
Table 69. Americas Opioids Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Opioids Drug Sales Forecast by Region (2025-2030) & (M Units)
Table 71. APAC Opioids Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Opioids Drug Sales Forecast by Country (2025-2030) & (M Units)
Table 73. Europe Opioids Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Opioids Drug Sales Forecast by Country (2025-2030) & (M Units)
Table 75. Middle East & Africa Opioids Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Opioids Drug Sales Forecast by Type (2025-2030) & (M Units)
Table 77. Global Opioids Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Opioids Drug Sales Forecast by Application (2025-2030) & (M Units)
Table 79. Global Opioids Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Teva Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Opioids Drug Product Portfolios and Specifications
Table 82. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Teva Main Business
Table 84. Teva Latest Developments
Table 85. Purdue Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Purdue Pharma Opioids Drug Product Portfolios and Specifications
Table 87. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Purdue Pharma Main Business
Table 89. Purdue Pharma Latest Developments
Table 90. Mallinckrodt Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Mallinckrodt Opioids Drug Product Portfolios and Specifications
Table 92. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Mallinckrodt Main Business
Table 94. Mallinckrodt Latest Developments
Table 95. Amneal Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Amneal Pharma Opioids Drug Product Portfolios and Specifications
Table 97. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Amneal Pharma Main Business
Table 99. Amneal Pharma Latest Developments
Table 100. Collegium Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Collegium Opioids Drug Product Portfolios and Specifications
Table 102. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Collegium Main Business
Table 104. Collegium Latest Developments
Table 105. J&J Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. J&J Opioids Drug Product Portfolios and Specifications
Table 107. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. J&J Main Business
Table 109. J&J Latest Developments
Table 110. Endo Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Endo Opioids Drug Product Portfolios and Specifications
Table 112. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Endo Main Business
Table 114. Endo Latest Developments
Table 115. Pfizer Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Opioids Drug Product Portfolios and Specifications
Table 117. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. INSYS Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. INSYS Opioids Drug Product Portfolios and Specifications
Table 122. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. INSYS Main Business
Table 124. INSYS Latest Developments
Table 125. Mylan Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Mylan Opioids Drug Product Portfolios and Specifications
Table 127. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Mylan Main Business
Table 129. Mylan Latest Developments
Table 130. Hikma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Hikma Opioids Drug Product Portfolios and Specifications
Table 132. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hikma Main Business
Table 134. Hikma Latest Developments
Table 135. Egalet Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Egalet Opioids Drug Product Portfolios and Specifications
Table 137. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Egalet Main Business
Table 139. Egalet Latest Developments
Table 1. Opioids Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Opioids Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oxycodone
Table 4. Major Players of Hydromorphone
Table 5. Major Players of Codeine
Table 6. Major Players of Fentanyl
Table 7. Global Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 8. Global Opioids Drug Sales Market Share by Type (2019-2024)
Table 9. Global Opioids Drug Revenue by Type (2019-2024) & ($ million)
Table 10. Global Opioids Drug Revenue Market Share by Type (2019-2024)
Table 11. Global Opioids Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 13. Global Opioids Drug Sales Market Share by Application (2019-2024)
Table 14. Global Opioids Drug Revenue by Application (2019-2024)
Table 15. Global Opioids Drug Revenue Market Share by Application (2019-2024)
Table 16. Global Opioids Drug Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Opioids Drug Sales by Company (2019-2024) & (M Units)
Table 18. Global Opioids Drug Sales Market Share by Company (2019-2024)
Table 19. Global Opioids Drug Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Opioids Drug Revenue Market Share by Company (2019-2024)
Table 21. Global Opioids Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Opioids Drug Producing Area Distribution and Sales Area
Table 23. Players Opioids Drug Products Offered
Table 24. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Opioids Drug Sales by Geographic Region (2019-2024) & (M Units)
Table 28. Global Opioids Drug Sales Market Share Geographic Region (2019-2024)
Table 29. Global Opioids Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Opioids Drug Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Opioids Drug Sales by Country/Region (2019-2024) & (M Units)
Table 32. Global Opioids Drug Sales Market Share by Country/Region (2019-2024)
Table 33. Global Opioids Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Opioids Drug Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Opioids Drug Sales by Country (2019-2024) & (M Units)
Table 36. Americas Opioids Drug Sales Market Share by Country (2019-2024)
Table 37. Americas Opioids Drug Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Opioids Drug Revenue Market Share by Country (2019-2024)
Table 39. Americas Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 40. Americas Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 41. APAC Opioids Drug Sales by Region (2019-2024) & (M Units)
Table 42. APAC Opioids Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Opioids Drug Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Opioids Drug Revenue Market Share by Region (2019-2024)
Table 45. APAC Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 46. APAC Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 47. Europe Opioids Drug Sales by Country (2019-2024) & (M Units)
Table 48. Europe Opioids Drug Sales Market Share by Country (2019-2024)
Table 49. Europe Opioids Drug Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Opioids Drug Revenue Market Share by Country (2019-2024)
Table 51. Europe Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 52. Europe Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 53. Middle East & Africa Opioids Drug Sales by Country (2019-2024) & (M Units)
Table 54. Middle East & Africa Opioids Drug Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Opioids Drug Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Opioids Drug Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Opioids Drug Sales by Type (2019-2024) & (M Units)
Table 58. Middle East & Africa Opioids Drug Sales by Application (2019-2024) & (M Units)
Table 59. Key Market Drivers & Growth Opportunities of Opioids Drug
Table 60. Key Market Challenges & Risks of Opioids Drug
Table 61. Key Industry Trends of Opioids Drug
Table 62. Opioids Drug Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Opioids Drug Distributors List
Table 65. Opioids Drug Customer List
Table 66. Global Opioids Drug Sales Forecast by Region (2025-2030) & (M Units)
Table 67. Global Opioids Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Opioids Drug Sales Forecast by Country (2025-2030) & (M Units)
Table 69. Americas Opioids Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Opioids Drug Sales Forecast by Region (2025-2030) & (M Units)
Table 71. APAC Opioids Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Opioids Drug Sales Forecast by Country (2025-2030) & (M Units)
Table 73. Europe Opioids Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Opioids Drug Sales Forecast by Country (2025-2030) & (M Units)
Table 75. Middle East & Africa Opioids Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Opioids Drug Sales Forecast by Type (2025-2030) & (M Units)
Table 77. Global Opioids Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Opioids Drug Sales Forecast by Application (2025-2030) & (M Units)
Table 79. Global Opioids Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Teva Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Opioids Drug Product Portfolios and Specifications
Table 82. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Teva Main Business
Table 84. Teva Latest Developments
Table 85. Purdue Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Purdue Pharma Opioids Drug Product Portfolios and Specifications
Table 87. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Purdue Pharma Main Business
Table 89. Purdue Pharma Latest Developments
Table 90. Mallinckrodt Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Mallinckrodt Opioids Drug Product Portfolios and Specifications
Table 92. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Mallinckrodt Main Business
Table 94. Mallinckrodt Latest Developments
Table 95. Amneal Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Amneal Pharma Opioids Drug Product Portfolios and Specifications
Table 97. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Amneal Pharma Main Business
Table 99. Amneal Pharma Latest Developments
Table 100. Collegium Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Collegium Opioids Drug Product Portfolios and Specifications
Table 102. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Collegium Main Business
Table 104. Collegium Latest Developments
Table 105. J&J Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. J&J Opioids Drug Product Portfolios and Specifications
Table 107. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. J&J Main Business
Table 109. J&J Latest Developments
Table 110. Endo Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Endo Opioids Drug Product Portfolios and Specifications
Table 112. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Endo Main Business
Table 114. Endo Latest Developments
Table 115. Pfizer Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Opioids Drug Product Portfolios and Specifications
Table 117. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. INSYS Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. INSYS Opioids Drug Product Portfolios and Specifications
Table 122. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. INSYS Main Business
Table 124. INSYS Latest Developments
Table 125. Mylan Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Mylan Opioids Drug Product Portfolios and Specifications
Table 127. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Mylan Main Business
Table 129. Mylan Latest Developments
Table 130. Hikma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Hikma Opioids Drug Product Portfolios and Specifications
Table 132. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hikma Main Business
Table 134. Hikma Latest Developments
Table 135. Egalet Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Egalet Opioids Drug Product Portfolios and Specifications
Table 137. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Egalet Main Business
Table 139. Egalet Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioids Drug
Figure 2. Opioids Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Drug Sales Growth Rate 2019-2030 (M Units)
Figure 7. Global Opioids Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Opioids Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Oxycodone
Figure 10. Product Picture of Hydromorphone
Figure 11. Product Picture of Codeine
Figure 12. Product Picture of Fentanyl
Figure 13. Global Opioids Drug Sales Market Share by Type in 2023
Figure 14. Global Opioids Drug Revenue Market Share by Type (2019-2024)
Figure 15. Opioids Drug Consumed in Pain Relief
Figure 16. Global Opioids Drug Market: Pain Relief (2019-2024) & (M Units)
Figure 17. Opioids Drug Consumed in Anesthesia
Figure 18. Global Opioids Drug Market: Anesthesia (2019-2024) & (M Units)
Figure 19. Opioids Drug Consumed in Others
Figure 20. Global Opioids Drug Market: Others (2019-2024) & (M Units)
Figure 21. Global Opioids Drug Sales Market Share by Application (2023)
Figure 22. Global Opioids Drug Revenue Market Share by Application in 2023
Figure 23. Opioids Drug Sales Market by Company in 2023 (M Units)
Figure 24. Global Opioids Drug Sales Market Share by Company in 2023
Figure 25. Opioids Drug Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Opioids Drug Revenue Market Share by Company in 2023
Figure 27. Global Opioids Drug Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Opioids Drug Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Opioids Drug Sales 2019-2024 (M Units)
Figure 30. Americas Opioids Drug Revenue 2019-2024 ($ Millions)
Figure 31. APAC Opioids Drug Sales 2019-2024 (M Units)
Figure 32. APAC Opioids Drug Revenue 2019-2024 ($ Millions)
Figure 33. Europe Opioids Drug Sales 2019-2024 (M Units)
Figure 34. Europe Opioids Drug Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Opioids Drug Sales 2019-2024 (M Units)
Figure 36. Middle East & Africa Opioids Drug Revenue 2019-2024 ($ Millions)
Figure 37. Americas Opioids Drug Sales Market Share by Country in 2023
Figure 38. Americas Opioids Drug Revenue Market Share by Country in 2023
Figure 39. Americas Opioids Drug Sales Market Share by Type (2019-2024)
Figure 40. Americas Opioids Drug Sales Market Share by Application (2019-2024)
Figure 41. United States Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Opioids Drug Sales Market Share by Region in 2023
Figure 46. APAC Opioids Drug Revenue Market Share by Regions in 2023
Figure 47. APAC Opioids Drug Sales Market Share by Type (2019-2024)
Figure 48. APAC Opioids Drug Sales Market Share by Application (2019-2024)
Figure 49. China Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Opioids Drug Sales Market Share by Country in 2023
Figure 57. Europe Opioids Drug Revenue Market Share by Country in 2023
Figure 58. Europe Opioids Drug Sales Market Share by Type (2019-2024)
Figure 59. Europe Opioids Drug Sales Market Share by Application (2019-2024)
Figure 60. Germany Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Opioids Drug Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Opioids Drug Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Opioids Drug Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Opioids Drug Sales Market Share by Application (2019-2024)
Figure 69. Egypt Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Opioids Drug in 2023
Figure 75. Manufacturing Process Analysis of Opioids Drug
Figure 76. Industry Chain Structure of Opioids Drug
Figure 77. Channels of Distribution
Figure 78. Global Opioids Drug Sales Market Forecast by Region (2025-2030)
Figure 79. Global Opioids Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Opioids Drug Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Opioids Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Opioids Drug Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Opioids Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Opioids Drug
Figure 2. Opioids Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Drug Sales Growth Rate 2019-2030 (M Units)
Figure 7. Global Opioids Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Opioids Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Oxycodone
Figure 10. Product Picture of Hydromorphone
Figure 11. Product Picture of Codeine
Figure 12. Product Picture of Fentanyl
Figure 13. Global Opioids Drug Sales Market Share by Type in 2023
Figure 14. Global Opioids Drug Revenue Market Share by Type (2019-2024)
Figure 15. Opioids Drug Consumed in Pain Relief
Figure 16. Global Opioids Drug Market: Pain Relief (2019-2024) & (M Units)
Figure 17. Opioids Drug Consumed in Anesthesia
Figure 18. Global Opioids Drug Market: Anesthesia (2019-2024) & (M Units)
Figure 19. Opioids Drug Consumed in Others
Figure 20. Global Opioids Drug Market: Others (2019-2024) & (M Units)
Figure 21. Global Opioids Drug Sales Market Share by Application (2023)
Figure 22. Global Opioids Drug Revenue Market Share by Application in 2023
Figure 23. Opioids Drug Sales Market by Company in 2023 (M Units)
Figure 24. Global Opioids Drug Sales Market Share by Company in 2023
Figure 25. Opioids Drug Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Opioids Drug Revenue Market Share by Company in 2023
Figure 27. Global Opioids Drug Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Opioids Drug Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Opioids Drug Sales 2019-2024 (M Units)
Figure 30. Americas Opioids Drug Revenue 2019-2024 ($ Millions)
Figure 31. APAC Opioids Drug Sales 2019-2024 (M Units)
Figure 32. APAC Opioids Drug Revenue 2019-2024 ($ Millions)
Figure 33. Europe Opioids Drug Sales 2019-2024 (M Units)
Figure 34. Europe Opioids Drug Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Opioids Drug Sales 2019-2024 (M Units)
Figure 36. Middle East & Africa Opioids Drug Revenue 2019-2024 ($ Millions)
Figure 37. Americas Opioids Drug Sales Market Share by Country in 2023
Figure 38. Americas Opioids Drug Revenue Market Share by Country in 2023
Figure 39. Americas Opioids Drug Sales Market Share by Type (2019-2024)
Figure 40. Americas Opioids Drug Sales Market Share by Application (2019-2024)
Figure 41. United States Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Opioids Drug Sales Market Share by Region in 2023
Figure 46. APAC Opioids Drug Revenue Market Share by Regions in 2023
Figure 47. APAC Opioids Drug Sales Market Share by Type (2019-2024)
Figure 48. APAC Opioids Drug Sales Market Share by Application (2019-2024)
Figure 49. China Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Opioids Drug Sales Market Share by Country in 2023
Figure 57. Europe Opioids Drug Revenue Market Share by Country in 2023
Figure 58. Europe Opioids Drug Sales Market Share by Type (2019-2024)
Figure 59. Europe Opioids Drug Sales Market Share by Application (2019-2024)
Figure 60. Germany Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Opioids Drug Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Opioids Drug Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Opioids Drug Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Opioids Drug Sales Market Share by Application (2019-2024)
Figure 69. Egypt Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Opioids Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Opioids Drug in 2023
Figure 75. Manufacturing Process Analysis of Opioids Drug
Figure 76. Industry Chain Structure of Opioids Drug
Figure 77. Channels of Distribution
Figure 78. Global Opioids Drug Sales Market Forecast by Region (2025-2030)
Figure 79. Global Opioids Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Opioids Drug Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Opioids Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Opioids Drug Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Opioids Drug Revenue Market Share Forecast by Application (2025-2030)
